- Home
- BRAG vs SAVA Comparison
BRAG vs SAVA Comparison
Compare BRAG & SAVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRAG
- SAVA
- Stock Information
- Founded
- BRAG 2018
- SAVA 1998
- Country
- BRAG Canada
- SAVA United States
- Employees
- BRAG N/A
- SAVA N/A
- Industry
- BRAG Office Equipment/Supplies/Services
- SAVA Biotechnology: Pharmaceutical Preparations
- Sector
- BRAG Technology
- SAVA Health Care
- Exchange
- BRAG Nasdaq
- SAVA Nasdaq
- Market Cap
- BRAG 123.3M
- SAVA 113.8M
- IPO Year
- BRAG N/A
- SAVA N/A
- Fundamental
- Price
- BRAG $5.55
- SAVA $2.41
- Analyst Decision
- BRAG Buy
- SAVA Buy
- Analyst Count
- BRAG 3
- SAVA 3
- Target Price
- BRAG $6.67
- SAVA $111.50
- AVG Volume (30 Days)
- BRAG 81.3K
- SAVA 2.2M
- Earning Date
- BRAG 03-25-2025
- SAVA 02-26-2025
- Dividend Yield
- BRAG N/A
- SAVA N/A
- EPS Growth
- BRAG N/A
- SAVA N/A
- EPS
- BRAG N/A
- SAVA N/A
- Revenue
- BRAG $109,522,641.00
- SAVA N/A
- Revenue This Year
- BRAG $11.40
- SAVA N/A
- Revenue Next Year
- BRAG $10.75
- SAVA N/A
- P/E Ratio
- BRAG N/A
- SAVA N/A
- Revenue Growth
- BRAG 4.64
- SAVA N/A
- 52 Week Low
- BRAG $2.86
- SAVA $2.23
- 52 Week High
- BRAG $7.00
- SAVA $42.20
- Technical
- Relative Strength Index (RSI)
- BRAG 78.15
- SAVA 28.52
- Support Level
- BRAG $4.70
- SAVA $2.30
- Resistance Level
- BRAG $5.59
- SAVA $2.48
- Average True Range (ATR)
- BRAG 0.25
- SAVA 0.13
- MACD
- BRAG 0.13
- SAVA 0.28
- Stochastic Oscillator
- BRAG 97.44
- SAVA 14.42
About BRAG Bragg Gaming Group Inc.
Bragg Gaming Group Inc is predominantly a B2B online gaming technology platform and casino content aggregator. The Company's proprietary studios offer high-performing, data-driven casino gaming titles from in-house brands Wild Streak, Spin, Atomic Slot Lab, Indigo Magic and Oryx Gaming. It offers a full range of games including slot games, table games, card games, video bingo, scratch card games, virtual sports, and live dealer games which are featured on the company's PAM platform and also available for use on other gaming platforms offered by third parties. Geographically, the company generates a majority of its revenue from the Netherlands and the rest from Curacao, Malta, United States, Croatia, and other regions.
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.